The Ƶ Criteria
Evidence Base
The Ƶ Criteria was built on a foundation of evidence around the multidimensional factors that influence disease severity and prognosis and expert consensus from a broad coalition of clinical stakeholders.
Peer-Reviewed Research on The Ƶ Criteria
Evidence-based medicine (EBM) is a perspective on clinical decision-making that has been defined as “… the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients … [by] integrating individual clinical expertise with the best available external clinical evidence from systematic research” (, p. 71).
The Ƶ Criteria was built on a foundation of evidence around the multidimensional factors that influence disease severity and prognosis and expert consensus from a broad coalition of clinical stakeholders. Since then, there have been more than two decades of peer-reviewed research on The Ƶ Criteria addressing outcomes relevant to feasibility, reliability, validity, accuracy, and effectiveness.
- . Stallvik, M; Gastfriend, DR; Nordahl, HM (2015) Journal of Substance Use, 20(6), 389-398.
- . Stallvik, M; Gastfriend, DR (2014) Addiction Research & Theory, 22(6), 515-523.
- . Angarita, GA; Reif, S; Pirard, S; Lee, S; Sharon, E; Gastfriend, DR (2007) Journal Of Addiction Medicine, 1(2), 79-87.
- Witbrodt, J; Bond, J; Kaskutas, LA; Weisner, C; Jaeger, G; Pating, D; Moore, C (2007) Journal Of Consulting And Clinical Psychology, 75(6), 947-959.
- . Magura, S; Fong, C; Staines, GL.; Cleland, C; Foote, J; Rosenblum, A; Kosanke, N; DeLuca, A (2005) Journal of Psychoactive Drugs, 37(1), 85-92.
- . Baker, SL; Gastfriend, DR (2003) Journal Of Addictive Diseases, 22 Suppl 1, 45-60.
- Deck, D; Gabriel, R; Knudsen, J; Grams, G (2003) Journal of addictive diseases, 22 Suppl 1, 27-44.
- . Magura, S; Staines, G; Kosanke, N; Rosenblum, A; Foote, J; DeLuca, A; Bali, P (2003) The American Journal On Addictions, 12(5), 386-397.
- . Sharon, E; Krebs, C; Turner, W; Desai, N; Binus, G; Penk, W; Gastfriend, DR (2003) Journal Of Addictive Diseases, 22 Suppl 1, 79-93.
- . Staines, G; Kosanke, N; Magura, S; Bali, P; Foote, J; Deluca, A (2003) Journal Of Addictive Diseases, 22 Suppl 1, 61-77.
- Kosanke, N; Magura, S; Staines, G; Foote, J; DeLuca, A (2002) The American Journal On Addictions, 11(2), 124-134.
- . Scott, CK; Foss, MA (2002) Journal Of Psychoactive Drugs, 34(1), 7-15.
- Turner, WM; Turner, KH; Reif, S; Gutowski, WE; Gastfriend, DR (1999) Drug And Alcohol Dependence, 55(2019), 35-43.
- McKay, JR; Cacciola, JS; McLellan, AT; Alterman, AI; Wirtz, PW (1997) Journal Of Studies On Alcohol, 58(3), 239-252.
- Stallvik, M; Nordahl, HM (2014) Journal Of Dual Diagnosis, 10(2), 68-78.
- Westermeyer, J; Lee, K (2013) The Journal Of Nervous And Mental Disease, 201(7), 567-571.
Real-World Implementation
Additional peer-reviewed research has explored variables that predict level of care placement, experiences in real-world implementations, processes for improving validity by learning from real world implementations, use in utilization management, and future research priorities.
- . Gastfriend DR, Rubin A, Sharon E, Turner WM, Anton RF, Donovan DM, Gorski T, Marlatt GA, Maisto S, Schultz TK, Shulman GD. (2003) J Addict Dis. 22 Suppl 1:95-111.
- . (2001) Rubin A, Gastfriend DR. Recent Dev Alcohol, 5:157-76.
- . Gregoire, TK (2000) Journal of Substance Abuse Treatment, 18(3), 241-248.
- . Heatherton B (2000) J Addict Disorders, 19(2):109-16.
- (2000) Gastfriend DR, Lu SH, Sharon E. Subst Use Misuse. 35(12-14):2191-213.
- (1997) Gastfriend DR, McLellan AT. Med Clin North Am. Jul;81(4):945-66.
- (1995) Book J, Harbin H, Marques C, Silverman C, Lizanich‐Aro S, Lazarus A. Am J on Addictions 4(3), 187-197.